Jason Tarkin
@Jmtarkin
Followers
279
Following
639
Media
18
Statuses
218
Wellcome Clinical Research Career Development Fellow & Hon Consultant Cardiologist @Cambridge_Uni | Jnr Research Fellow @Catz_Cambridge | BSCI/BSCCT committee
Joined March 2020
Sharing this amazing review of coronary atherosclerotic plaque biology - a GREAT read for coronary imagers by the incomparable Professor Renu Virmani! Article: https://t.co/Fbzm5U3Znu
3
21
64
Excited to be working with @robhinchliffe1 @DrMarcBailey @Jmtarkin @coughlin_pa Dave Newby, Marc Dweck & Michelle Williams with @allisoncwin heading things up as the research fellow!
0
2
4
Come and work at @HLRI_Cambridge in Cambridge with my colleague @Jmtarkin as a Clinical Research Associate. You will learn vascular imaging, clinical trials and get some immunology experience. Advert here -
0
5
6
Our new paper looking at imaging microcalcification in atherosclerotic plaque is now out: 18F-NaF uptake on vascular PET imaging in symptomatic versus asymptomatic atherosclerotic disease: A meta-analysis. @CamStroke @mm_chowdhury1 @Jmtarkin @jhfrudd
https://t.co/Zet6VdLbEP
journals.sagepub.com
Introduction: 18F-sodium fluoride (NaF) positron-emission tomography (PET) is increasingly being used to measure microcalcification in atherosclerotic disease ...
0
7
14
Delighted to share our recent publication using diffusion tensor cardiovascular magnetic resonance in the European Heart Journal @ESC_Journals @ehj_ed led by our outstanding fellow @RRajakulasingam. https://t.co/yocAHIHEIs
academic.oup.com
AbstractBackground and Aims. Microstructural disturbances underlie dysfunctional contraction and adverse left ventricular (LV) remodelling after ST-elevati
1
8
37
Congratulations to @dgiakomidi for winning the best post doc poster at the @MedCambridge Research Day! Because gut microbiota rocks! @HLRI_Cambridge @Cambridgecardio @TheBHF We had a fantastic day at the #DOMResearchDay2024
0
7
16
1
4
14
Thank you @CircAHA for this opportunity⬇️! Another piece of the puzzle🧩...providing a better understanding of the mechanism of colchicine on plaque and systemic immune effects. Check out https://t.co/D6VFUCtXao
@AbbateAntonio @garshick @lfbpharmd @RonBlankstein @cpcannon
ahajournals.org
BACKGROUND: Colchicine has been approved to reduce cardiovascular risk in patients with coronary heart disease on the basis of its potential benefits demonstrated in the COLCOT (Colchicine Cardiova...
#Editorial Affordable and widely available Colchicine shows promise in reducing atherothrombotic risk in ASCVD by stabilizing coronary plaques and reducing inflammation. @bweber04 @AbbateAntonio
https://t.co/Z2yXOHh0Py
0
5
36
Imperial #VPM2024 – Day Two is Live! Join us for today's sessions, streaming free on the Millbrook Hub—accessible via desktop or through our app! Today's Agenda Features: 💙Future of Coronary CT 💙Combined Intravascular Imaging: Clinical Impact 💙Updates in Nuclear and
0
3
8
Stenosis : nothing else matters? Well, don’t forget high risk plaque, total plaque volume, pericoronary FAI... plus physiological indicators of ischaemia as predictors of future adverse event @fairbairn_tim #BSCImaging2024
0
2
3
Data from this initiative will also serve to improve our understanding of inflammation in cardiovascular disease as a whole - @Jmtarkin @Bweber04 @AbbateAntonio @MMukherjeeMD @VasculitisUK @clecliniclondon @CleClinicHVTI @ImperialNHS @ImperialNHLI @ImperialMed
0
2
6
New content online! Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases https://t.co/UUKdsrFdhI
2
30
64
Using machine learning to predict carotid artery symptoms from CT angiography: A radiomics and deep learning approach: https://t.co/uim3CE5LGA
@Jmtarkin @JWeirMcCall @HLRI_Cambridge @rouchelle45 @andrejcorovic @nr_evans @caromitreka @EvisSala @MedCambridge @Cambridgecardio
0
9
13
In HTx recipients, FAI was an independent predictor of MACEs and allograft rejection. FAI assessment could be part of CCTA analysis in routine surveillance of HTx recipients, potentially improving pts' care. https://t.co/iNQi1vJYpQ
#JACCIMG #ESCCongress @Ang_Sanso
0
12
51
Great talk by @andrejcorovic at #ESCCongress2024 on SST2 PET/MR imaging of residual post-infarct myocardial inflammation! @jhfrudd @Meri421_cam @ZMallat @YuanHuang86 @zahifayad @HLRI_Cambridge @Cambridgecardio @MedCambridge
3
9
28
🚨📢 Listen up cardiovascular imagers!! 👀🫶 The @BSClmaging online education team are proud to announce the launch of the BSCI Moodle platform: the largest collection of #cvi lectures in the UK - all given by experts in the field and free to all members. Happy learning!
1
9
23
Incredibly proud of my friend and colleague @neiljcraig for a fantastic #ESCongress YIA presentation on PET assessments of fibroblast activation in the valve & myocardium in #AorticStenosis 👏🏼 🫀 Fantastic images & discussion, 10/10 for using a photo of Skye as the background!
1
5
30
📌Join us next week at the British Atherosclerosis Society (BAS) Annual Meeting 2024 in Cambridge Including Early Career Investigator Awards, Hugh Sinclair memorial lecture by Dr Cornelia Weyand, & more! Register now: https://t.co/mpF2W8FXbi
@britathsoc #CardiovascularResearch
3
11
21
We are delighted to see @ZMallat @rouchelle45 & team from #HLRI sharing their fabulous work on the IVORY trial with delegates at #ESCCongress - this is exactly what @HLRI_Cambridge is all about! #TranslationForPatientBenefit
@Cambridge_Uni @CambridgeBRC @TheBHF @NIHRresearch
Congratulations @ZMallat for making it from bench to bedside!!! IVORY results released by @rouchelle45 at #ESCCongress Low dose IL2 safely reduce arterial inflammation after ASC @HLRI_Cambridge @Cambridgecardio @MedCambridge @TheBHF
7
5
16